The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients-Reference-Cited by-同舟云学术

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

Published:2012-01 Issue:1 Volume:206 Page:58.e1-58.e8
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Verlohren Stefan,Herraiz Ignacio,Lapaire Olav,Schlembach Dietmar,Moertl Manfred,Zeisler Harald,Calda Pavel,Holzgreve Wolfgang,Galindo Alberto,Engels Theresa,Denk Barbara,Stepan Holger

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference40 articles.

1. WHO analysis of causes of maternal death: a systematic review;Khan;Lancet,2006

2. The global impact of pre-eclampsia and eclampsia;Duley;Semin Perinatol,2009

3. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005;Berg;Obstet Gynecol,2009

4. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy;Roberts;Hypertens Pregnancy,2003

5. Diagnosis and management of gestational hypertension and preeclampsia;Sibai;Obstet Gynecol,2003

Cited by 357 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sFlt-1/PlGF-ratio and the risk of preeclampsia-related adverse outcomes in subsequent pregnancies with signs and symptoms of a preeclampsia;Pregnancy Hypertension;2024-09

2. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing;American Journal of Obstetrics and Gynecology;2024-09

3. Significance of the sFlt-1/PlGF Ratio in Certain Cohorts – What Needs to be Considered?;Geburtshilfe und Frauenheilkunde;2024-07

4. Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial;American Heart Journal;2024-05

5. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach;Bioactive Materials;2024-04